Last $0.05 USD
Change Today -0.001 / -2.13%
Volume 30.1K
HDVY On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

health discovery corp (HDVY) Snapshot

Open
$0.04
Previous Close
$0.05
Day High
$0.05
Day Low
$0.04
52 Week High
06/8/12 - $0.10
52 Week Low
02/28/13 - $0.03
Market Cap
10.8M
Average Volume 10 Days
63.7K
EPS TTM
$-0.01
Shares Outstanding
233.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HEALTH DISCOVERY CORP (HDVY)

Related News

No related news articles were found.

health discovery corp (HDVY) Related Businessweek News

No Related Businessweek News Found

health discovery corp (HDVY) Details

Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. Its intellectual property includes Support Vector Machines (SVM), Fractal Genomic Modeling (FGM), and biomarkers. The SVMs are mathematical algorithms that allow computers to sift through datasets to identify patterns; recursive feature elimination SVM identify and rank order the data points that contribute the desired results; FGM enhances the mapping of genetic pathways involved in the diagnosis and prevention of certain diseases; and biomarkers are biological indicators or genetic expression signatures of certain disease states. The company’s licensing and development products comprise genetic biomarker signature that identifies prostate cancer cells; breast cancer diagnostic technologies, such as MammoSIGHT for detecting malignancy in mammograms and MetastaSIGHT for identifying circulating tumor cells in the blood; molecular diagnostic tests for detecting pancreatic cancer; a subset of genes that separates benign prostatic hyperplasia from prostate cancer; and colon cancer-specific biomarkers for use in the development of diagnostic assays. Its development products also include MelApp, a mobile phone application to take a picture of a mole, lesion, or birthmark and receive a risk assessment for melanoma and other skin cancer; a diagnostic test to interpret flow cell cytometry data for myelodysplastic syndrome; a software tool for cytogenetic analysis; and a set of image processing operations to isolate abnormal cells in a digitized Pap smear image. The company holds a license agreement with NeoGenomics Laboratories, Inc. to develop and sell products in laboratory testing, molecular diagnostics, clinical pathology, anatomic pathology, and digital image analysis fields. Health Discovery Corporation was founded in 2001 and is based in Hanson, Massachusetts.

5 Employees
Last Reported Date: 03/29/13
Founded in 2001

health discovery corp (HDVY) Top Compensated Officers

Chief Executive Officer, Principal Financial ...
Total Annual Compensation: $175.0K
Chief Operating Officer and Vice President of...
Total Annual Compensation: $13.8K
Senior Vice President of Computational Medici...
Total Annual Compensation: $132.0K
Consultant
Total Annual Compensation: $641.9K
Compensation as of Fiscal Year 2012.

health discovery corp (HDVY) Key Developments

Health Discovery Corporation Appoints Norman Mineta to Board of Directors

Health Discovery Corporation announced that Secretary Norman Mineta has joined Health Discovery Corporation's Board of Directors.

Health Discovery Corporation Appoints David Eckoff to the Board of Directors Replacing Herbert A. Fritsche

On February 25, 2013, Mr. David Eckoff accepted an invitation to join the Board of Directors of Health Discovery Corporation, replacing Dr. Herbert A. Fritsche. Mr. Eckoff, age 48, is an experienced entrepreneur, technological innovator, and corporate executive with more than twenty-five years of experience. Mr. Eckoff is Co-Founder of Pickoff LLC. Previously, Mr. Eckoff was Vice President, New Products at Turner Broadcasting.

Health Discovery Corporation Announces Executives Changes

Health Discovery Corporation announced that on December 18, 2012, the board of directors appointed Dr. John Norris as its new CEO. He succeeds Dr. Stephen Barnhill, who founded of the company, served as Chairman and CEO for 9 years. Dr. Norris, 65, until his appointment as CEO, was Executive Vice President, Chief Technology Officer, and Chief Regulatory Officer of the company and had served in that capacity for the past three years.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HDVY:US $0.05 USD -0.001

HDVY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Diagnocure Inc C$0.27 CAD +0.005
Imperial Innovations Group PLC 280.00 GBp -4.00
MDxHealth €2.01 EUR -0.02
Miraculins Inc C$0.07 CAD -0.005
Vermillion Inc $3.08 USD 0.00
View Industry Companies
 

Industry Analysis

HDVY

Industry Average

Valuation HDVY Industry Range
Price/Earnings 31.5x
Price/Sales 6.8x
Price/Book NM Not Meaningful
Price/Cash Flow 27.0x
TEV/Sales 4.6x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTH DISCOVERY CORP, please visit www.healthdiscoverycorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.